Glucocorticoid-Induced Bone Disease

Intermittent Parathyroid Hormone Administration Counteracts the Adverse Effects of Glucocorticoids on Osteoblast and Osteocyte Viability, Bone Formation, and Strength in Mice

(2010) Robert S. Weinstein et al.   ENDOCRINOLOGY

Bisphosphonates and Fractures of the Subtrochanteric or Diaphyseal Femur

(2010) Dennis M. Black et al.   NEW ENGLAND JOURNAL OF MEDICINE

American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis

(2010) Jennifer M. Grossman et al.   ARTHRITIS CARE & RESEARCH

Endogenous glucocorticoids decrease skeletal angiogenesis, vascularity, hydration, and strength in aged mice

(2009) Robert S. Weinstein et al.   AGING CELL

Effects of denosumab on bone mineral density and bone turnover in patients with rheumatoid arthritis receiving concurrent glucocorticoids or bisphosphonates

(2009) R. K. Dore et al.   ANNALS OF THE RHEUMATIC DISEASES

The use of alendronate in the treatment of avascular necrosis of the femoral head

(2009) S. Agarwala et al.   JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME

Age Dependence of Early Symptomatic Vertebral Fracture with High-Dose Glucocorticoid Treatment for Collagen Vascular Diseases

(2009) Ichiro Tatsuno et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Baseline Glucocorticoid Dose and Bone Mineral Density Response with Teriparatide or Alendronate Therapy in Patients with Glucocorticoid-induced Osteoporosis

(2009) J.-P. DEVOGELAER et al.   JOURNAL OF RHEUMATOLOGY

Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial

(2009) David M Reid et al.   LANCET

Giant Osteoclast Formation and Long-Term Oral Bisphosphonate Therapy

(2009) Robert S. Weinstein et al.   NEW ENGLAND JOURNAL OF MEDICINE

Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis

(2009) Steven R. Cummings et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety of parathyroid hormone for the treatment of osteoporosis

(2008) Paul D. Miller   Current Osteoporosis Reports